Revolutionize Treatment Through Personalization
Employ genetic profiling and analytics to tailor therapy to individual patients. Our solutions incorporate genomic and molecular data to match the right therapies, drugs and doses to each person's specific disease risk and biology. This approach transforms how conditions are diagnosed and managed.
Whole genome and exome sequencing identifies rare mutations driving conditions to guide targeted or emerging therapies personalized at the DNA level.
02
Pharmacogenomics
Analysis of genetics informs how a person's body metabolizes certain drugs or their potential side effects. This helps select the most effective medications and dosages for each patient.
03
Liquid Biopsy
Non-invasive blood tests detect molecular markers to aid early cancer detection, recurrence monitoring and therapy selection with simple and repeated samples over the course of care.
04
Companion Diagnostics
Molecular diagnostic tests, such as immunohistochemistry, FISH or PCR, are developed alongside new therapies to identify the patients most likely to benefit from specific precision treatments.
Case study 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laborisLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
Go to Use Case Title
What Are the Results You Should Expect?
Effectiveness
Tailored care based on individual biological characteristics like genetics maximizes response likelihood for patients.
Safety
Predictive models help avoid adverse reactions by guiding therapy selection based on predispositions.
Efficiency
Targeted upfront options improve success rates versus less personalized trial-and-error approaches.
Insights
Analytics across multiple data sources accelerates new discoveries compared to traditional clinical trials alone.